![Jackie Papkoff](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jackie Papkoff
Plus aucun poste en cours
Historique de carrière de Jackie Papkoff
Anciens postes connus de Jackie Papkoff
Sociétés | Poste | Début | Fin |
---|---|---|---|
California Innovation Center | Corporate Officer/Principal | - | - |
ASSEMBLY BIOSCIENCES, INC. | Corporate Officer/Principal | 02/04/2018 | - |
EVELO BIOSCIENCES, INC. | Directeur Technique/Scientifique/R&D | - | - |
CFD Therapeutics, Inc.
![]() CFD Therapeutics, Inc. Medical SpecialtiesHealth Technology CFD Therapeutics, Inc. (CFD), is being created to develop novel cancer therapeutics stemming from discoveries made previously by diaDexus. CFD will specifically focus on the development of therapeutic monoclonal antibodies directed against proprietary ovarian, pancreatic, breast, colon, prostate and lung cancer targets licensed from diaDexus. diaDexus, Inc. and San Francisco-based Biotechnology Value Fund L.P | Directeur Technique/Scientifique/R&D | 17/09/2009 | - |
Formation de Jackie Papkoff
University of California, Santa Cruz | Undergraduate Degree |
University of California San Diego | Doctorate Degree |
The Salk Institute for Biological Studies | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 8 |
Opérationnelle
Chief Tech/Sci/R&D Officer | 2 |
Corporate Officer/Principal | 2 |
Doctorate Degree | 2 |
Sectorielle
Health Technology | 4 |
Consumer Services | 4 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
ASSEMBLY BIOSCIENCES, INC. | Health Technology |
EVELO BIOSCIENCES, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
CFD Therapeutics, Inc.
![]() CFD Therapeutics, Inc. Medical SpecialtiesHealth Technology CFD Therapeutics, Inc. (CFD), is being created to develop novel cancer therapeutics stemming from discoveries made previously by diaDexus. CFD will specifically focus on the development of therapeutic monoclonal antibodies directed against proprietary ovarian, pancreatic, breast, colon, prostate and lung cancer targets licensed from diaDexus. diaDexus, Inc. and San Francisco-based Biotechnology Value Fund L.P | Health Technology |
California Innovation Center |
- Bourse
- Insiders
- Jackie Papkoff
- Expérience